Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol versus morphine versus placebo for endogenous pain modulation in chronic neuropathic pain and healthy volunteers
2010-023175-26Phase 4Active
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tapentadol and morphine in chronic pain, Neuralgia and small fiber neuropathy (SFN) (3 arms), sponsored by Leiden University Medical Center. Primary endpoint: Endogenous modulation of pain. Started Oct 2010; status: active.
02
Drugs
tapentadolmorphine
03
Conditions
chronic painNeuralgiasmall fiber neuropathy (SFN)
Beyond the preview
Go deeper on 2010-023175-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023175-26.